|
|
Volumn 7, Issue 1, 2001, Pages 114-116
|
|
Are recombinant products really infection risk free?
|
|
Author keywords
Clinical significance; Source materials; Viral contamination
|
|
Indexed keywords
BACTERIAL VACCINE;
BIOLOGICAL PRODUCT;
BLOOD CLOTTING FACTOR;
BLOOD CLOTTING FACTOR 8;
GROWTH HORMONE;
MEASLES VACCINE;
POLIOMYELITIS VACCINE;
RABIES VACCINE;
RECOMBINANT DNA;
SMALLPOX VACCINE;
UROKINASE;
VIRUS VACCINE;
YELLOW FEVER VACCINE;
ANIMAL CELL;
ARTICLE;
CELL CULTURE;
CELL STRAIN BHK;
CHO CELL;
CONTROLLED STUDY;
DIPLOIDY;
DRUG CONTAMINATION;
DRUG MANUFACTURE;
DRUG SAFETY;
FERMENTATION;
HEPATITIS C VIRUS;
HUMAN;
HUMAN CELL;
INFECTION RISK;
MOUSE;
NONHUMAN;
PARVOVIRUS;
PRIORITY JOURNAL;
RECOMBINANT DNA TECHNOLOGY;
VALIDATION PROCESS;
VERO CELL;
VIRUS INACTIVATION;
VIRUS TRANSMISSION;
BLOOD COAGULATION FACTORS;
HUMANS;
RECOMBINANT PROTEINS;
RISK;
VIRUS DISEASES;
|
|
EID: 0035131497
PISSN: 13518216
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2516.2001.00467.x Document Type: Article |
|
Times cited : (7)
|
|
References (2)
|
